Skip to content

A Randomized Controlled Trial of Ultrasound-Guided Interscalene-Axillary Combined Brachial Plexus Block for Anesthesia Effectiveness in Emergency Department Forearm Fracture Reduction

A Randomized Controlled Trial of Ultrasound-Guided Interscalene-Axillary Combined Brachial Plexus Block for Anesthesia Effectiveness in Emergency Department Forearm Fracture Reduction

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600125567
Enrollment
Unknown
Registered
2026-05-28
Start date
2026-05-28
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Forearm Fracture

Interventions

Combined Brachial Plexus Block Group :Ultrasound-guided interscalene-axillary combined brachial plexus block (15 mL of 0.33% ropivacaine at each site)
Single Interscalene Block Group :Ultrasound-guided single interscalene brachial plexus block (30 mL of 0.33% ropivacaine)

Sponsors

Anyue County Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age and gender (1) Age >=60 years old; (2) No restriction on gender; 2. Physical status (1) ASA physical status classification Grade I-II; 3. Fracture type (1) Unilateral fresh closed distal forearm fractures; 1) Including Colles fracture; 2) Including Smith fracture; 3) Including Barton fracture; 4. Time to consultation (1) The time from fracture onset to medical consultation <= 72 hours; 5. Informed consent (1) Voluntary participation in this study; (2) Signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Combined with severe cardiovascular and cerebrovascular diseases (1) e.g., uncontrolled hypertension; (2) heart failure; (3) severe arrhythmia; 2. Contraindications to nerve block (1) Infection at the puncture site; (2) Coagulation disorders (PLT 1.5); (3) Allergy to local anesthetics; 3. Complicated with severe respiratory system diseases (1) e.g., COPD; (2) Acute exacerbation of asthma; (3) Abnormal diaphragmatic function; 4. Complicated with neurological diseases (1) e.g., peripheral neuropathy; (2) multiple sclerosis; 5. Special populations (1) Pregnant or lactating women; 6. Cognitive and mental status (1) Combined with mental illness or cognitive dysfunction; (2) Unable to cooperate with evaluation; 7. Fracture conditions (1) Bilateral fractures or multiple injuries; (2) Pathological fracture or open fracture.

Design outcomes

Primary

MeasureTime frame
Rate of satisfactory sensory block of brachial plexus;

Secondary

MeasureTime frame
VAS pain score during reduction ;Onset time of sensory block;Duration of sensory block;Onset time of motor block;Duration of motor block;Intraoperative fentanyl rescue rate and total dose;Surgeon satisfaction with muscle relaxation;Hemodynamic parameters (heart rate, blood pressure, SpO2);

Countries

China

Contacts

Public ContactYao Yi

Anyue County Hospital of Traditional Chinese Medicine

475551320@qq.com+86 135 5170 1703

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 11, 2026